Status:
COMPLETED
Secretin Activates Human Brown Fat and Induces Satiation.
Lead Sponsor:
Turku University Hospital
Collaborating Sponsors:
Technical University of Munich
Conditions:
Obesity
Eligibility:
MALE
18-65 years
Phase:
PHASE2
PHASE3
Brief Summary
15 healthy males will be studied with PET/CT, using FDG to investigate glucose metabolism, and radiowater to investigate perfusion. One scan will be performed in controlled cold exposure, to see wheth...
Detailed Description
The PET/CT study will consist of 15 healthy, normal weight males, between ages 18-65. A 2-hour oral glucose tolerance test is performed on screening day. Calorimetry data is collected at baseline (res...
Eligibility Criteria
Inclusion
- healthy normal weight
Exclusion
- cardiovascular disease, diabetes
- smoking
Key Trial Info
Start Date :
August 2 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2019
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT03290846
Start Date
August 2 2016
End Date
November 30 2019
Last Update
December 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Turku PET Centre
Turku, Finland, 20521